Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical has been lauded for its ESG (environmental, social, and governance) performance by prominent sustainability rating agencies S&P Global and FTSE Russell. This recognition includes their selection in the S&P Global Sustainability Yearbook (China Edition) for the second year and their inaugural inclusion in the FTSE4Good Index. The company is committed to integrating ESG principles with its growth strategies and to contributing to a healthier world.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.